Charles River Laboratories Intl. Inc vs Public Storage — how do they compare? Charles River Laboratories Intl. Inc trades at $284.99 (market cap $13.46B), while Public Storage trades at $324.37 (market cap $60.71B). The key difference: Public Storage is far larger — about 4.5× Charles River Laboratories Intl. Inc's market cap, and Public Storage pays a 3.69% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals.
| CRL | PSA | |
|---|---|---|
Market Cap | $13.46B | $60.71B |
Sector | Health | Real Estate |
52-Week High | $282.00 | $330.47 |
52-Week Low | $145.57 | $258.44 |
Enterprise Value | $16.30B | $74.98B |
Dividend Yield | — | 3.69% |
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $277.00, up 3.56% on the day and near its 52-week high of $277.07, reflecting strong bullish momentum. The stock exhibits positive technical signals with moving averages indicating an uptrend, though oscillators suggest overbought conditions. Fundamentally, the company reported Q2 2026 EPS of $3.02, beating estimates, and raised full-year guidance, yet faces profitability challenges with a negative net income margin of -5.96% and elevated valuation ratios like a P/E of 684.85. Recent news highlights improved biotech demand and institutional buying interest.
The outlook for CRL is cautiously optimistic, driven by earnings beats and raised guidance, but high valuation and weak profitability pose risks. Investment opportunity lies in sustained demand for drug development services, while risks include margin pressure, debt levels, and sensitivity to biotech funding cycles. The stock's proximity to all-time highs warrants monitoring for pullbacks.
Public Storage (PSA) trades at $325.71, down 0.82% on the day, with a bullish technical outlook supported by moving averages. The REIT maintains strong profitability with 41.8% net income margin and has beaten earnings estimates for three consecutive quarters. Recent developments include the completed acquisition of National Storage Affiliates and consistent $3.00 quarterly dividends, positioning the company for growth through expansion and operational efficiency.
PSA presents a mixed investment case with premium valuation metrics (P/E 31.02) offset by strong fundamentals and growth initiatives. The consensus price target of $333.88 suggests modest upside potential, though elevated P/E and P/B ratios warrant caution. Key risks include interest rate sensitivity and integration challenges from recent acquisitions, while the stable dividend and expansion into Canada provide growth catalysts.
Trailing returns across standard periods
Latest headlines on both assets
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →Public Storage is the largest owner of self-storage facilities in the U.S. with more than 2,800 self-storage facilities in 39 states and approximately 200 million square feet of rentable space. Through equity interests, it also has exposure to the European self-storage market through Shurgard Self Storage and to an additional 28 million net rentable square feet of industrial space in the United States through PS Business Parks.
Read more on PSA →